• Return to Headlines

Shares of Momenta Pharmace Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (MNTA , CHRS , AGIO , PTCT , AKBA )

By Amy Schwartz

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Momenta Pharmace (NASDAQ:MNTA ) ranks first with a gain of 4.74%; Coherus Bioscien (NASDAQ:CHRS ) ranks second with a gain of 4.50%; and Agios Pharmaceut (NASDAQ:AGIO ) ranks third with a gain of 3.96%.

Ptc Therapeutics (NASDAQ:PTCT ) follows with a gain of 3.67% and Akebia Therapeut (NASDAQ:AKBA ) rounds out the top five with a gain of 2.52%.

SmarTrend recommended that its subscribers protect gains by selling shares of Momenta Pharmace on August 2nd, 2018 by issuing a Downtrend alert when the shares were trading at $28.40. Since that call, shares of Momenta Pharmace have fallen 60.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: relative performance momenta pharmace coherus bioscien agios pharmaceut ptc therapeutics akebia therapeut

Ticker(s): MNTA CHRS AGIO PTCT AKBA